Core Insights - FibroBiologics, Inc. is a clinical-stage biotechnology company focused on developing therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials [1][3] - The company holds over 270 patents issued and pending, covering various clinical pathways including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer [3] Company Presentation - The Founder and CEO, Pete O'Heeron, will present at the 9th Annual BFC Global Healthcare Business Development and Investment Conference on January 11, 2026, at 4:30 p.m. PT [1][2] Company Overview - FibroBiologics is based in Houston and represents the next generation of medical advancement in cell therapy and tissue regeneration [3] - The company is actively developing a pipeline of treatments aimed at chronic diseases [3]
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference